|
Fasting lipid profiles in subject groups |
||||
| Parameter |
CTL |
HYPER |
HYPO |
ANOVA |
|
|
||||
| N |
30 |
46 |
23 |
<0.0001 |
| TG (mmol/L) |
1.14 ± 0.12 |
0.73 ± 0.06**,††† |
1.74 ± 0.09*** |
<0.0001 |
| TChol (mmol/L) |
4.58 ± 0.15 |
2.72 ± 0.14***,††† |
6.16 ± 0.24*** |
<0.0001 |
| LDL-C (mmol/L) |
2.40 ± 0.16 |
1.41 ± 0.09***,††† |
3.66 ± 0.18*** |
<0.0001 |
| HDL-C (mmol/L) |
1.56 ± 0.06 |
0.99 ± 0.04*** |
1.74 ± 0.07††† |
<0.0001 |
| NEFA (mmol/L) |
0.361 ± 0.03 |
0.617 ± 0.05*** |
0.425 ± 0.03††† |
<0.0001 |
|
Results are expressed as average ± SEM for the four groups indicated as control (CTL), hyperthyroid (HYPER) and hypothyroid (HYPO) where TG = plasma triglyceride, TChol = total cholesterol, LDL-C = LDL cholesterol, HDL-C = HDL cholesterol and NEFA = non-esterified fatty acids. Significance was calculated by ANOVA with Bonferroni post-hoc test where differences vs. control (CTL) group are indicated as *P < 0.05,**P < 0.01,***P < 0.001; and differences between hyperthyroid and hypothyroid are indicated as †p < 0.05, ††p < 0.01, †††p < 0.001. | ||||
Yu et al. Nutrition & Metabolism 2006 3:13 doi:10.1186/1743-7075-3-13 |
||||